BioSpace News Archive

Pharm Country

Merck to Showcase Oncology Pipeline Amid Concerns About Dependence on Keytruda

While Merck’s Keytruda has racked up nearly 20 approvals from the U.S. Food and Drug Administration, there is some investor concern that the company is too dependent on the product for its future.

June 19, 2019
·
3 min read
·
Alex Keown
Biotech Beach

Denovo Biopharma Acquires Global Rights to Experimental Alzheimer’s Drug

Denovo’s new asset will target the Alpha2C adrenoceptor.

June 19, 2019
·
2 min read
·
Alex Keown
Drug Development

Polyphor announces enrollment of first patient in FORTRESS Phase III clinical trial for balixafortide in combination with eribulin in patients with metastatic breast cancer

Balixafortide is the most advanced and only CXCR4 antagonist in development in a pivotal Oncology global registration trial.

June 19, 2019
·
5 min read
Drug Development

Bavarian Nordic Initiates Phase 3 Trial of Freeze-dried MVA-BN® Smallpox Vaccine

Bavarian Nordic A/S announced the initiation of a pivotal Phase 3 trial of the freeze-dried formulation of MVA-BN® smallpox vaccine in 1,110 healthy, vaccinia-naïve subjects.

June 19, 2019
·
4 min read
Business

Comet Therapeutics Earns $28.5 Million Series A with Sight Set on Metabolic Diseases

Comet has set up shop in Kendall Square with about 10 employees. The company has plans to expand to at least double that amount over the next year as it moves from the preclinical phase to the clinical phase.

June 19, 2019
·
3 min read
·
Alex Keown
Business

Paper Outlines New Thinking and Knowledge of CRISPR and Off-Target Analysis

When Becky Fu met Brett Robb at a CRISPR conference four years ago, they were both deeply involved in CRISPR. The two published a paper in March in Nature Microbiology on the subject and on Fu’s findings on the complex mechanisms of the Cpf1 nucleases, a different set of enzymes than the often-used Cas9.

June 19, 2019
·
4 min read
·
Mark Terry
Deals

Resolutions Of The Annual General Meeting 2019 Of Evotec SE

Evotec SE announced that its shareholders approved all proposals the Company’s Management put to vote at the Company’s Annual General Meeting 2019 with very strong supporting majorities.

June 19, 2019
·
4 min read
Business

Catalent to Buy Bristol-Myers’ Factory in Italy, Adding to Latest String of Expansions

The facility has acted as one of Bristol-Myers Squibb’s primary launch facilities for new drugs. After the deal is closed, Catalent will continue to manufacture Bristol-Myers Squibb’s current product portfolio at that location.

June 19, 2019
·
3 min read
·
Mark Terry
BioMidwest

Researchers ID 14 Genes Linked to Survival in Pediatric Liver Disease

The team of scientists also found that N-acetyl-cysteine, an antioxidant, decreased liver injury and fibrosis in mice with biliary atresia, resulting in increased survival times.

June 19, 2019
·
3 min read
·
Mark Terry
Drug Development

BioSpace Global Roundup, June 20

Biotech and pharma companies from across Europe and Asia share company and pipeline updates.

June 19, 2019
·
4 min read
·
Alex Keown